using a thromboxane a2 receptor antagonist in the manufacture of a arzeneimittels treatment pulmonarer hypertension induced by protamine neutralization of heparin is caused.

摘要

A method is provided for preventing, reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.